Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49
United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Kathleen Ford
29 Sep 2026
Chief Operating Officer
Sold on a plan
3,668
$10.75
$39.44K
Kathleen Ford
28 Sep 2026
Chief Operating Officer
Sold on a plan
6,906
$10.50
$72.49K
Teresa Brophy Bair
28 Sep 2026
Chief Legal Officer
Sold on a plan
8,442
$10.50
$88.62K
Brian T. Powl
21 Aug 2026
Chief Commercial Officer
Sold on a plan
4,345
$11.89
$51.66K
Teresa Brophy Bair
19 Aug 2026
Chief Legal Officer
Sold on a plan
31,487
$12.63
$397.68K
Mollie Leoni
18 Jun 2026
Chief Medical Officer
Sold on a plan
84,929
$9.82
$834.28K
Brian T. Powl
21 May 2026
Chief Commercial Officer
Sold on a plan
10,000
$11.00
$110.00K
Kathleen Ford
19 May 2026
Chief Operating Officer
Sold on a plan
2,257
$9.08
$20.48K
Brian T. Powl
19 May 2026
Chief Commercial Officer
Sold on a plan
339
$9.21
$3.12K
Teresa Brophy Bair
18 May 2026
Chief Legal Officer
Sold on a plan
2,256
$9.38
$21.16K
Kathleen Ford
14 Nov 2025
Chief Operating Officer
Sold on a plan
6,902
$11.18
$77.14K
Teresa Brophy Bair
14 Nov 2025
Chief Legal Officer
Sold on a plan
8,804
$11.18
$98.40K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 3
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 749,020
History held since 10 Mar 2015